Literature DB >> 7270459

Effect of aging on the electrocardiogram.

S Bachman, D Sparrow, L K Smith.   

Abstract

Previous cross-sectional population studies have shown age differences in electrocardiographic wave patterns, including lower wave amplitudes and a leftward shift of the frontal plane axis in older people. However, cross-sectional results may be due to cohort differences and the data imply only that these changes actually occur in persons as they age. In order to examine electrocardiographic changes with aging in the same persons, serial recordings, obtained 10 years apart, were taken in 440 healthy male participants of the Normative Aging Study, who were 23 to 66 years old on their first examination. At examination 1, R and S wave amplitudes were smaller and frontal plane axis measurements were shifted to the left in older men. Longitudinal changes in these same variables were consistent with the cross-sectional results. In addition, the P-R and Q-T interval durations were longer, the QRS duration was shorter and the T wave amplitude was smaller at the second examination. The longitudinal rate of change of S wave amplitude varied among age groups, decreasing more in younger men. Thus, some previously described cross-sectional age differences truly represent longitudinal age trends in electrocardiographic patterns.

Entities:  

Mesh:

Year:  1981        PMID: 7270459     DOI: 10.1016/0002-9149(81)90081-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Monitoring normal and aberrant electrocardiographic activity from an endotracheal tube: comparison of the surface, esophageal, and tracheal electrocardiograms.

Authors:  J K Hayes; J L Peters; K W Smith; C M Craven
Journal:  J Clin Monit       Date:  1994-03

2.  Demographic and Methodological Heterogeneity in Electrocardiogram Signals From Guinea Pigs.

Authors:  Kazi T Haq; Blake L Cooper; Fiona Berk; Anysja Roberts; Luther M Swift; Nikki Gillum Posnack
Journal:  Front Physiol       Date:  2022-06-02       Impact factor: 4.755

3.  Electrocardiographic effects of probucol. A controlled prospective clinical trial.

Authors:  C A Dujovne; F Atkins; B Wong; S DeCoursey; P Krehbiel; S B Chernoff
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Factors related to QT interval prolongation during probucol treatment.

Authors:  Y Ohya; K Kumamoto; I Abe; Y Tsubota; M Fujishima
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  SIRT2 induces the checkpoint kinase BubR1 to increase lifespan.

Authors:  Brian J North; Michael A Rosenberg; Karthik B Jeganathan; Angela V Hafner; Shaday Michan; Jing Dai; Darren J Baker; Yana Cen; Lindsay E Wu; Anthony A Sauve; Jan M van Deursen; Anthony Rosenzweig; David A Sinclair
Journal:  EMBO J       Date:  2014-05-12       Impact factor: 11.598

6.  Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.

Authors:  L Carosella; P Menichelli; M Alimenti; G Zuccala; A Gemma; A Cocchi; P U Carbonin
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

7.  Detailed analysis of the impact of age on the QT interval.

Authors:  Simon W Rabkin; Xin-Bo Justin Cheng; Darby Js Thompson
Journal:  J Geriatr Cardiol       Date:  2016-09       Impact factor: 3.327

8.  Are ECG changes in heart-healthy individuals of various ages related to cardiac disease 20 years later?

Authors:  Sofia Erelund; Kjell Karp; Urban Wiklund; Rolf Hörnsten; Sandra Arvidsson
Journal:  Ups J Med Sci       Date:  2021-05-21       Impact factor: 2.384

9.  Aging effects on QT interval: Implications for cardiac safety of antipsychotic drugs.

Authors:  Simon W Rabkin
Journal:  J Geriatr Cardiol       Date:  2014-03       Impact factor: 3.327

10.  Automated and Interpretable Patient ECG Profiles for Disease Detection, Tracking, and Discovery.

Authors:  Geoffrey H Tison; Jeffrey Zhang; Francesca N Delling; Rahul C Deo
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-09-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.